22818-40-2; D-4-Hydroxyphenylglycine; D(-)-4-Hydroxyphenylglycine; 4-Hydroxy-D-phenylglycine; H-D-PHG(4-OH)-OH; D-(-)-4-Hydroxyphenylglycine; (R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID; D-N-(4-Hydroxyphenyl)glycine; (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid; (R)-alpha-Amino-4-hydroxybenzeneacetic acid; 4-Hydroxyphenylglycine, D-(-)-; D-P-HYDROXYPHENYLGLYCINE; p-hydroxy-D-phenylglycine; PCM9OIX717; (2R)-amino(4-hydroxyphenyl)acetic acid; P-hydroxy-(R)-phenylglycine; (R)-2-(4-HYDROXYPHENYL)GLYCINE; D-(-)-p-Hydroxyphenylglycine; CHEBI:15695; (R)-(4-HYDROXYPHENYL)GLYCINE; D-(-)-amino(4-hydroxyphenyl)acetic acid; (2R)-amino(4-hydroxyphenyl)ethanoic acid; D-2-amino-2-(p-hydroxyphenyl)acetic acid; D-(-)-2-(P-HYDROXYPHENYL)GLYCINE; (R)-Ethyl 2-amino-2-(4-hydroxyphenyl)acetate; MFCD00004262; UNII-PCM9OIX717; Benzeneacetic acid, .alpha.-amino-4-hydroxy-, (.alpha.R)-; Benzeneacetic acid, a-amino-4-hydroxy-, (aR)-; EINECS 245-247-7; Cefprozil impurity A; (alphaR)-alpha-Amino-4-hydroxybenzeneacetic acid; 4-HYDROXY-D-(-)-2-PHENYLGLYCINE; d-4-hydroxyphenylglicyne; Cefprozil EP Impurity A; Epitope ID:117718; EC 245-247-7; SCHEMBL124861; D-?-(4-hydroxyphenyl)glycine; Benzeneacetic acid, alpha-amino-4-hydroxy-, (alphaR)-; D-alpha-(4-hydroxyphenyl)glycine; DTXSID401014840; ZINC157101; (R)-(4-Hydroxyphenyl)glycine; (R)-2-(4-Hydroxyphenyl)glycine; 4-Hydroxy-D-phenylglycine; D-(-)-2-(4-Hydroxyphenyl)glycine; D-(-)-2-(p-Hydroxyphenyl)glycine; 4-Hydroxy-D-phenylglycine, >=98%; D-(-)-2-(4-Hydroxyphenyl)glycine; AKOS006281607; AKOS015924172; AC-1085; DB04308; (R)--Amino-4-hydroxybenzeneacetic acid; D-.ALPHA.-P-HYDROXYPHENYLGLYCINE; NCGC00164509-02; (-)-4-Hydroxy-D-phenylglycine, 98+%; AS-12542; HY-34588; CEFPROZIL IMPURITY A [EP IMPURITY]; CEFADROXIL IMPURITY A [EP IMPURITY]; AMOXICILLIN IMPURITY I [EP IMPURITY]; CS-0020117; GLYCINE, 2-(P-HYDROXYPHENYL)-, D-; H0758; C03493; D71081; EN300-105272; D-(-)-.ALPHA.-(4-HYDROXYPHENYL)GLYCINE; A816374; D-.ALPHA.-AMINO-4-HYDROXYPHENYLACETIC ACID; AMOXICILLIN TRIHYDRATE IMPURITY I [EP IMPURITY]; CEFADROXIL MONOHYDRATE IMPURITY A [EP IMPURITY]; CEFPROZIL MONOHYDRATE IMPURITY A [EP IMPURITY]; Q27095129; D-(-)-.ALPHA.-AMINO-4-HYDROXYPHENYLACETIC ACID; Z1198149764; (R)-(-)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID; (.ALPHA.R)-.ALPHA.-AMINO-4-HYDROXYBENZENEACETIC ACID; Cefprozil impurity A, European Pharmacopoeia (EP) Reference Standard; (2R)-2-azaniumyl-2-(4-hydroxyphenyl)acetate;(R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid; D-alpha-(4-Hydroxy-phenyl)glycine, European Pharmacopoeia (EP) Reference Standard; Amoxicillin EP Impurity I; (2R)-2-Amino-2-(4-hydroxyphenyl)acetic acid; (R)-(4-Hydroxyphenyl)glycine; (R)-Ethyl 2-Amino-2-(4-hydroxyphenyl)acetate